Trial Will Test Calcitriol on Bone Health; Now Recruiting in Boston

Trial Will Test Calcitriol on Bone Health; Now Recruiting in Boston

286825

Trial Will Test Calcitriol on Bone Health; Now Recruiting in Boston

A Phase 1 trial is enrolling children and adults with X‐linked hypophosphatemia (XLH) to assess the effects of calcitriol, the active form of vitamin D, on kidney function and bone health. Already underway at Massachusetts General Hospital, in Boston, the trial (NCT03748966) is looking to recruit 20 participants with XLH, ages 6 to 70. For information on enrollment and contacts, please visit the trial’s page here. Mutations in the gene PHEX, the cause of XLH, lead…

You must be logged in to read/download the full post.